University Of Gothenburg

6 trials 3 recruiting Academic / non-commercial

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

1 Completed trials

3 Countries active

8 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 3 Phase IV: 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Top IMPs

3-(3-METHANESULFONYL-PHENYL)-1-PROPYL-PIPERIDINE HYDROCHLORIDE 2 IXEKIZUMAB 1 METFORMIN HYDROCHLORIDE 1 PLACEBO 1

All trials

6 total

OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety Pending

2024-513894-35-00 Phase II 1 country 3-(3-METHANESULFONYL-PHENYL)-1-PROPYL-PIPERIDINE HYDROCHLORIDE; PLACEBO
OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID) Pending

2024-517560-30-00 Phase II 1 country 3-(3-METHANESULFONYL-PHENYL)-1-PROPYL-PIPERIDINE HYDROCHLORIDE
STunning in Acute Myocardial Infarction – Beta blockers, Angiotensin converting enzyme inhibitors and Sodium/glucose cotransporter 2 inhibit… Recruiting

2024-511789-35-00 Phase IV 1 country
Preeclampsia Intervention 4 Recruiting

2022-502707-29-00 Phase III 3 countries METFORMIN HYDROCHLORIDE
A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers Recruiting

2024-512612-22-00 Phase III 1 country
Ixekizumab Diabetes Intervention Trial (I-DIT) Ended

2023-508588-58-00 Phase II 1 country IXEKIZUMAB

Showing 1–6 of 6 trials

← All sponsors A–Z